| Literature DB >> 10562971 |
M Green1, M G Michaels, S A Webber, D Rowe, J Reyes.
Abstract
Despite a growing understanding of the pathogenesis and spectrum of Epstein-Barr virus (EBV) and EBV-associated post-transplant lymphoproliferative disease (PTLD) in organ transplant recipients, the optimal management of this complication remains controversial. The absence of comparative data evaluating potential therapeutic strategies explains the lack of uniformly accepted guidelines for the management of PTLD. The purpose of this review is to provide an overview of potential therapies and offer a set of guidelines for the management of EBV-associated PTLD in children.Entities:
Mesh：
Substances：
Year: 1999 PMID： 10562971 DOI： 10.1034/j.1399-3046.1999.00066.x
Source DB: PubMed Journal: Pediatr Transplant ISSN： 1397-3142